Recombinant Human Hyaluronidase/Pertuzumab/Trastuzumab Regimen

Preferred Label : Recombinant Human Hyaluronidase/Pertuzumab/Trastuzumab Regimen;

NCIt synonyms : Hyaluronidase-zzxf/Pertuzumab/Trastuzumab Regimen; Recombinant Human Hyaluronidase-Pertuzumab-Trastuzumab Regimen; Phesgo Regimen; Pertuzumab/Trastuzumab/Hyaluronidase-zzxf Regimen;

NCIt related terms : Pertuzumab and Trastuzumab hyaluronidase monotherapy;

NCIt definition : A regimen consisting of a fixed-dose combination of three agents: recombinant human hyaluronidase, pertuzumab and trastuzumab, that may be used in the treatment of breast cancer.;

NCI Metathesaurus CUI : CL1794046;

Codes from synonyms : 120663;

Details

Origin ID

C188892;

UMLS CUI

C5708107;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Hyaluronidase-zzxf/Pertuzumab/Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- Single-agent Therapeutic Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients